Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Caveolin-3 in muscular dystrophy

E M McNally1, E de Sá Moreira, D J Duggan

  • 1Division of Genetics and the Howard Hughes Medical Institute, Children's Hospital, Boston, MA 02115, USA. emcnally@medicine.bsd.uchicago.edu

Human Molecular Genetics
|May 23, 1998
PubMed
Summary

Mutations in the caveolin-3 gene are linked to muscular dystrophy. Researchers identified two specific amino acid changes in caveolin-3 associated with this muscle-wasting disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Taking on the Titin: Muscle imaging as a diagnostic marker of biallelic <i>TTN-</i>related myopathy.

Journal of neuromuscular diseases·2025
Same author

MSTO1 mutations cause mtDNA depletion, manifesting as muscular dystrophy with cerebellar involvement.

Acta neuropathologica·2019
Same author

Facilitating orphan drug development: Proceedings of the TREAT-NMD International Conference, December 2015, Washington, DC, USA.

Neuromuscular disorders : NMD·2017
Same author

Expansion of the GLE1-associated arthrogryposis multiplex congenita clinical spectrum.

Clinical genetics·2016
Same author

Mutation-specific effects on thin filament length in thin filament myopathy.

Annals of neurology·2016
Same author

212th ENMC International Workshop: Animal models of congenital muscular dystrophies, Naarden, The Netherlands, 29-31 May 2015.

Neuromuscular disorders : NMD·2016

Area of Science:

  • Muscle biology
  • Cellular structures
  • Genetic disorders

Background:

  • The dystrophin-glycoprotein complex (DGC) is crucial for muscle integrity, linking the cytoskeleton to the extracellular matrix.
  • Defects in DGC proteins cause muscular dystrophy, often leading to reduced levels of other associated proteins.
  • Caveolae, involved in cellular functions like signal transduction, utilize caveolin proteins for structural roles.

Purpose of the Study:

  • To investigate the role of caveolin-3, a muscle-specific caveolin protein, in muscular dystrophy.
  • To identify mutations in the caveolin-3 gene associated with muscular dystrophy.

Main Methods:

  • Co-purification assays to determine caveolin-3's association with dystrophin.
  • Gene isolation, chromosomal mapping (3p25), and genomic organization analysis of human caveolin-3.

Related Experiment Videos

  • Screening of 82 muscular dystrophy patients for mutations in the caveolin-3 gene.

    • Main Results:

    • Caveolin-3 was found to co-purify with dystrophin, indicating it is a dystrophin-associated protein.
    • Two distinct nucleotide changes resulting in amino acid substitutions (G55S and C71W) were identified in patients.
    • These identified mutations were absent in the control population and located in a functionally significant domain of caveolin-3.

    Conclusions:

    • The identified mutations in caveolin-3 are likely disease-causing, contributing to muscular dystrophy.
    • Caveolin-3 plays a significant role in muscle function and its genetic alterations can lead to muscle disease.